These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29030229)

  • 1. Elevation of Proenkephalin 143-183 in Cerebrospinal Fluid in Moyamoya Disease.
    Yokoyama K; Maruwaka M; Yoshikawa K; Araki Y; Okamoto S; Sumitomo M; Kawamura A; Sakamoto Y; Shimizu K; Izumi T; Wakabayashi T
    World Neurosurg; 2018 Jan; 109():e446-e459. PubMed ID: 29030229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Maruwaka M; Yoshikawa K; Okamoto S; Araki Y; Sumitomo M; Kawamura A; Yokoyama K; Wakabayashi T
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):104-11. PubMed ID: 25440344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease.
    Kim SK; Yoo JI; Cho BK; Hong SJ; Kim YK; Moon JA; Kim JH; Chung YN; Wang KC
    Stroke; 2003 Dec; 34(12):2835-41. PubMed ID: 14605320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proenkephalin A 119-159, a stable proenkephalin A precursor fragment identified in human circulation.
    Ernst A; Köhrle J; Bergmann A
    Peptides; 2006 Jul; 27(7):1835-40. PubMed ID: 16621157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease-A Proteome Analysis of Cerebrospinal Fluid.
    Kashiwazaki D; Uchino H; Kuroda S
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2981-2987. PubMed ID: 28843803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midregional Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation.
    Ernst A; Buerger K; Hartmann O; Dodel R; Noelker C; Sommer N; Schwarz M; Köhrle J; Bergmann A; Hampel H
    J Neuroimmunol; 2010 Apr; 221(1-2):62-7. PubMed ID: 20207019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.
    Araki Y; Yoshikawa K; Okamoto S; Sumitomo M; Maruwaka M; Wakabayashi T
    BMC Neurol; 2010 Nov; 10():112. PubMed ID: 21059247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob Disease.
    Abu-Rumeileh S; Barschke P; Oeckl P; Baiardi S; Mammana A; Mastrangelo A; Al Shweiki MR; Steinacker P; Ladogana A; Capellari S; Otto M; Parchi P
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cellular retinoic acid-binding protein-I (CRABP-I) in the cerebrospinal fluid of adult onset moyamoya disease and its association with clinical presentation and postoperative haemodynamic change.
    Jeon JS; Ahn JH; Moon YJ; Cho WS; Son YJ; Kim SK; Wang KC; Bang JS; Kang HS; Kim JE; Oh CW
    J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):726-31. PubMed ID: 24292994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enkephalin-containing polypeptides in human cerebrospinal fluid.
    Nyberg F; Nylander I; Terenius L
    Brain Res; 1986 Apr; 371(2):278-86. PubMed ID: 2870778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 7.0- and 3.0-T MRI and MRA in ischemic-type moyamoya disease: preliminary experience.
    Deng X; Zhang Z; Zhang Y; Zhang D; Wang R; Ye X; Xu L; Wang B; Wang K; Zhao J
    J Neurosurg; 2016 Jun; 124(6):1716-25. PubMed ID: 26544772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis.
    Jeon JP; Yun T; Jin X; Cho WS; Son YJ; Bang JS; Kang HS; Oh CW; Kim JE; Park S
    Medicine (Baltimore); 2015 May; 94(17):e629. PubMed ID: 25929894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proenkephalin as a new biomarker for pediatric acute kidney injury - reference values and performance in children under one year of age.
    Hartman SJF; Zwiers AJM; van de Water NEC; van Rosmalen J; Struck J; Schulte J; Hartmann O; Pickkers P; Beunders R; Tibboel D; Schreuder MF; de Wildt SN
    Clin Chem Lab Med; 2020 Oct; 58(11):1911-1919. PubMed ID: 32598298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SDF-1/CXCR4 axis participants in the pathophysiology of adult patients with moyamoya disease.
    Ren S; Han Q; Zhou P; Wang Z; Huang Y
    J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107717. PubMed ID: 38608825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proenkephalin A and proopiomelanocortin peptides in human cerebrospinal fluid.
    Liu DX; Wood GW; Desiderio DM
    J Chromatogr; 1990 Sep; 530(2):235-52. PubMed ID: 1964161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease.
    Nanba R; Kuroda S; Ishikawa T; Houkin K; Iwasaki Y
    Stroke; 2004 Dec; 35(12):2837-42. PubMed ID: 15528455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in moyamoya disease.
    Wang G; Wen Y; Chen S; Zhang G; Li M; Zhang S; Qi S; Feng W
    CNS Neurosci Ther; 2021 Aug; 27(8):908-918. PubMed ID: 33942536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of proenkephalin A, proopiomelanocortin and protachykinin neuropeptides in human lumbar cerebrospinal fluid by reversed-phase high-performance liquid chromatography, radioimmunoassay and enzymolysis.
    Harajiri S; Wood G; Desiderio DM
    J Chromatogr; 1992 Mar; 575(2):213-22. PubMed ID: 1629297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system vasculitis and moyamoya disease: similarities and differences.
    Kraemer M; Berlit P
    J Neurol; 2010 May; 257(5):816-9. PubMed ID: 20037765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial relationship between cerebral microbleeds, moyamoya vessels, and hematoma in moyamoya disease.
    Kazumata K; Shinbo D; Ito M; Shichinohe H; Kuroda S; Nakayama N; Houkin K
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1421-8. PubMed ID: 24529354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.